Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.34% |
| 2 | Technology | 12.68% |
| 3 | Consumer Discretionary | 10.4% |
| 4 | Financials | 10.32% |
| 5 | Consumer Staples | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BBQ
2201
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
| $2.32M | ﹤0.01% |
474,247
-3,952
| -0.8% | -$18.3K |
|
2202
Global Ship Lease
GSL
$1.52B
| $2.32M | ﹤0.01% |
302,875
+49,900
| +20% | +$367K |
|
|
HA
2203
DELISTED
Hawaiian Holdings, Inc.
HA
| $2.31M | ﹤0.01% |
88,100
+6,000
| +7% | +$158K |
|
2204
Identive
INVE
$64.1M
| $2.31M | ﹤0.01% |
438,761
+43,291
| +11% | +$214K |
|
2205
Garrett Motion
GTX
$5.41B
| $2.3M | ﹤0.01% |
231,349
-347,051
| -60% | -$4.26M |
|
|
VRS
2206
DELISTED
Verso Corporation
VRS
| $2.3M | ﹤0.01% |
+185,800
| New | +$2.54M |
|
2207
Interparfums
IPAR
$3.67B
| $2.3M | ﹤0.01% |
32,813
-6,900
| -17% | -$458K |
|
2208
TETRA Technologies
TTI
$1.27B
| $2.29M | ﹤0.01% |
1,141,716
+406,530
| +55% | +$698K |
|
|
MN
2209
DELISTED
MANNING & NAPIER, INC.
MN
| $2.29M | ﹤0.01% |
1,219,199
+1,500
| +0.1% | +$2.66K |
|
2210
Mustang Bio
MBIO
$4.5M
| $2.29M | ﹤0.01% |
937
+216
| +30% | +$591K |
|
2211
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
| $2.29M | ﹤0.01% |
27,000
-23,366
| -46% | -$1.98M |
|
2212
Full House Resorts
FLL
$81.7M
| $2.29M | ﹤0.01% |
1,059,744
+49,721
| +5% | +$94.8K |
|
2213
NeoGenomics
NEO
$2.05B
| $2.29M | ﹤0.01% |
+119,500
| New | +$2.8M |
|
2214
Goldgroup Mining Inc.
GORO
$207M
| $2.28M | ﹤0.01% |
748,869
-960,761
| -56% | -$3.37M |
|
2215
Lesaka Technologies
LSAK
$407M
| $2.28M | ﹤0.01% |
638,700
-107,100
| -14% | -$390K |
|
2216
CarParts.com
PRTS
$47.1M
| $2.27M | ﹤0.01% |
146,801
+21,344
| +17% | +$285K |
|
|
FOCS
2217
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $2.27M | ﹤0.01% |
95,600
+56,400
| +144% | +$1.39M |
|
2218
ProPetro Holding
PUMP
$1.49B
| $2.27M | ﹤0.01% |
249,400
+42,500
| +21% | +$590K |
|
|
FCSC
2219
DELISTED
Fibrocell Science Inc.
FCSC
| $2.26M | ﹤0.01% |
763,754
+23,300
| +3% | +$47.8K |
|
2220
LeMaitre Vascular
LMAT
$1.88B
| $2.26M | ﹤0.01% |
66,100
+2,500
| +4% | +$79.9K |
|
|
RADA
2221
DELISTED
Rada Electronic Industries Ltd
RADA
| $2.25M | ﹤0.01% |
472,924
-10,044
| -2% | -$42.2K |
|
|
PPIH
2222
Perma-Pipe International
PPIH
$218M
| $2.25M | ﹤0.01% |
233,278
+16,715
| +8% | +$146K |
|
2223
Metropolitan Bank Holding Corp
MCB
$1.17B
| $2.23M | ﹤0.01% |
56,783
+14,483
| +34% | +$585K |
|
|
LBC
2224
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $2.23M | ﹤0.01% |
196,866
+17,266
| +10% | +$188K |
|
|
BCRH
2225
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
| $2.23M | ﹤0.01% |
301,900
+68,600
| +29% | +$516K |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.